- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in glenmark pharmaceuticals
Glenmark receives 'India Pharma Innovation of the Year' Award from the govt. of India
Glenmark receives 'India Pharma Innovation of the Year' Award from the govt. of India
Read MoreGlenmark launches SUTIB (Sunitinib) - priced 96% lower than the innovator brand- Reduces the risk of kidney cancer progression by 58%
Glenmark launches SUTIB (Sunitinib) - priced 96% lower than the innovator brand- Reduces the risk of kidney cancer progression by 58%
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Topiramate Extended-release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Extended-release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg, 10 mg
Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg, 10 mg
Read MoreGlenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg
Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg
Read MoreRecently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure
Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg
Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg
Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg
Read MoreGlenmark introduces NINDANIB (Nintedanib) and is amongst the first to launch the branded generic version at an affordable cost for the treatment of Pulmonary Fibrosis in India
Glenmark introduces NINDANIB (Nintedanib) and is amongst the first to launch the branded generic version at an affordable cost for the treatment of Pulmonary Fibrosis in India
Read MoreGlenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg
Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg
Read MoreGlenmark appoints Dipankar Bhattacharjee to its Board of Directors
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
Read More
Glenmark Introduces Higher Strength Of Fabiflu To Reduce Pill Burden Of Covid-19 Treatment
The higher strength will improve patient compliance and experience by effectively reducing the number of tablets that patients require per day
Read More
Glenmark Cuts COVID-19 Drug Favipiravir Price By 27 %
"Our priority from the start of this pandemic has been to offer patients in India an effective treatment for COVID-19 while also ensuring accessibility to the masses,"
Read MoreFitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rating
Fitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rating
Read More